全关节置换术后使用大麻与风险增加相关?一项Meta分析
该系统综述与Meta分析纳入19篇文献,评估全关节置换术(TJA)患者使用大麻与并发症、疼痛、阿片类药物消耗及医疗资源利用的关系。大麻使用与全膝关节置换术(TKA)后深静脉血栓(DVT)和翻修风险升高相关,与TKA费用升高相关;在全髋关节置换术(THA)中DVT风险无显著差异。大麻使用未改变疼痛评分、阿片类药物消耗或THA费用。
要点
- 大麻使用与TKA后DVT风险升高相关(OR 1.46,95%CI 1.13-1.89)。
- 大麻使用与TKA后翻修风险升高相关(OR 1.47,95%CI 1.41-1.53)。
- 大麻使用与TKA费用升高相关(估计值$3,552.46,95%CI $1,729.71-$5,375.22)。
核心结论
- 大麻使用可能与TJA后DVT、翻修、肺炎、脑血管意外和心脏并发症风险增加相关。
- 需要更高级别研究来确定大麻使用对TJA患者的影响。
研究设计与样本
- 系统综述与Meta分析,检索5个数据库,纳入2012年1月至2022年7月间报告TJA后大麻使用与并发症、疼痛管理、阿片类药物消耗、住院时间、费用或功能结局的研究。
- 最终分析共纳入19篇文章,对比值比(OR)和连续变量进行Meta分析。
主要发现
- 大麻使用与TKA后DVT风险升高相关(OR 1.46,95%CI 1.13-1.89)。
- 大麻使用与TKA后翻修风险升高相关(OR 1.47,95%CI 1.41-1.53)。
- 大麻使用与THA后DVT风险无显著差异(OR 1.30,95%CI 0.79-2.13)。
- 大麻使用与TKA后肺栓塞风险无显著差异(OR 1.29,95%CI 0.95-1.77),与THA后肺栓塞风险无显著差异(OR 0.55,95%CI 0.09-3.28),与TKA后心血管并发症风险无显著差异(OR 1.97,95%CI 0.93-4.14)。
- 大麻使用未改变疼痛评分、阿片类药物消耗或THA费用(估计值$2,550.51,95%CI $356.58-$5,457.62),但与TKA费用升高相关(估计值$3,552.46,95%CI $1,729.71-$5,375.22)。
关键数值与推荐
- TKA后DVT:大麻使用OR 1.46(95%CI 1.13-1.89)。
- TKA后翻修:大麻使用OR 1.47(95%CI 1.41-1.53)。
- THA后DVT:大麻使用OR 1.30(95%CI 0.79-2.13)。
- TKA后肺栓塞:大麻使用OR 1.29(95%CI 0.95-1.77);THA后肺栓塞:OR 0.55(95%CI 0.09-3.28)。
- TKA后心血管并发症:大麻使用OR 1.97(95%CI 0.93-4.14)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更高级别研究来确定大麻使用对TJA患者的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the increased legalization of cannabis, a new unknown emerges for orthopaedic surgeons and their patients. This systematic review aimed to (1) evaluate complications of cannabis use; (2) determine the effects of cannabis on pain and opioid consumption; and (3) evaluate healthcare utilizations associated with cannabis use among patients undergoing total joint arthroplasty (TJA). METHODS: A systematic review was performed. A search of the literature was performed in 5 databases. We included studies between January 2012 and July 2022 reporting cannabis use and complications, pain management, opioid consumption, length of stay, costs, or functional outcomes following TJA. A meta-analysis of odds ratios (ORs) and continuous variables was performed. A total of 19 articles were included in our final analysis. RESULTS: Cannabis use was associated with higher odds for deep vein thrombosis (DVT) (OR: 1.46, 95% Confidence Interval [CI]: 1.13 to 1.89) and revisions (OR: 1.47 [95% CI: 1.41 to 1.53]) in total knee arthroplasty (TKA). Cannabis use was associated with similar odds for DVT in total hip arthroplasty (THA) (OR: 1.30 [95% CI: 0.79 to 2.13]), pulmonary embolus in both TKA (OR: 1.29 [95% CI: 0.95 to 1.77]), THA (OR: 0.55 [95% CI: 0.09 to 3.28]), and cardiovascular complications in TKA (OR: 1.97 [95% Cl: 0.93 to 4.14]). Cannabis use did not alter pain scores, opioid consumption, or cost of care in THA (estimate: $2,550.51 [95% CI: $356.58 to $5,457.62]) but was associated with higher costs in TKA (estimate: $3,552.46 [95% CI: $1,729.71 to $5,375.22]). There was no difference in lengths of stay or functional outcomes; however, there may be a potentially increased risk for prosthetic complications, pneumonia, and cerebrovascular accidents among cannabis users. CONCLUSION: Cannabis use may be associated with an increased risk of DVTs, revisions, pneumonia, cerebrovascular accidents, and cardiac complications after TJA. Higher-level studies are needed to ascertain the impact of cannabis use for patients undergoing TJA.
引用
- Turan OA, Rullan PJ, Pasqualini I, et al. Cannabis Use Following Total Joint Arthroplasty is Associated With Increased Risks? A Meta-Analysis. J Arthroplasty. 2023. PMID: 37454951. doi:10.1016/j.arth.2023.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。